Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.
Mentions
2 mentions · latest on 22 Aug 2026
| The No Pile | - | 22 Aug 2026 | |
| Terns Pharma: Derisked Allosteric Inhibitors $tern | - | 8 Apr 2026 |